Cardea Bio
Semiconductors, 4900 Avalon RDG Pkwy, San Diego, California, 30071, United States, 11-50 Employees
Phone Number: 61********
Who is CARDEA BIO
Cardea Bio is the worlds only mass producer of biocompatible semiconductors, the BPUTM (Biosignal Processing Unit). The BPU is the first and only semiconductor capable of translating real...
Read More
-
Headquarters: 4900 Avalon RDG Pkwy, San Diego, California, 30071, United States
-
Date Founded: 2019
-
Employees: 11-50
-
Revenue: $250 Million to $500 Million
-
Active Tech Stack: See technologies
Industry: Semiconductors
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from CARDEA BIO
Cardea Bio Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Cardea Bio
Answer: Cardea Bio's headquarters are located at 4900 Avalon RDG Pkwy, San Diego, California, 30071, United States
Answer: Cardea Bio's phone number is 61********
Answer: Cardea Bio's official website is https://cardeabio.com
Answer: Cardea Bio's revenue is $250 Million to $500 Million
Answer: Cardea Bio's SIC: 2836
Answer: Cardea Bio's NAICS: 541714
Answer: Cardea Bio has 11-50 employees
Answer: Cardea Bio is in Semiconductors
Answer: Cardea Bio contact info: Phone number: 61******** Website: https://cardeabio.com
Answer: Cardea Bio is the worlds only mass producer of biocompatible semiconductors, the BPUTM (Biosignal Processing Unit). The BPU is the first and only semiconductor capable of translating real-time streams of multiomics signals into digital information. Through the BPUTM platform, Cardea's long-term vision is to democratize access to the biosignals and insights behind the most advanced technology on our planet: Nature and biology. The Internet of Biology is that way becoming possible. Cardea is headquartered in San Diego and has additional activity in Los Angeles. Cardea is a 100% American developed and built biocompatible semiconductor technology for applications across a variety of sectors including human health, agriculture, molecular diagnostics, biotechnology, environmental monitoring, and animal health. In May 2023, Cardea Bio became part of Paragraf, who has revolutionized graphene electronic device manufacturing with its pioneering scalable approach, making it the world's first company to achieve this feat. The acquisition of Cardea Bio and creation of Paragraf USA will enable Paragraf to offer a new generation of biosensing devices that will deliver the features and result sensitivity of existing lab-based instruments, with the rapid response and simple ease of use required to enable handheld, real-time, in the field use.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month